Moody Lynn & Lieberson LLC Raises Stock Holdings in Axon Enterprise, Inc $AXON

Moody Lynn & Lieberson LLC grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 24.2% in the second quarter, Holdings Channel reports. The institutional investor owned 7,192 shares of the biotechnology company’s stock after acquiring an additional 1,403 shares during the quarter. Moody Lynn & Lieberson LLC’s holdings in Axon Enterprise were worth $5,955,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in AXON. TCI Wealth Advisors Inc. purchased a new stake in Axon Enterprise in the 2nd quarter worth $214,000. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in shares of Axon Enterprise during the first quarter worth about $1,110,000. Quotient Wealth Partners LLC acquired a new position in shares of Axon Enterprise during the 1st quarter worth about $438,000. CX Institutional purchased a new position in Axon Enterprise in the 1st quarter valued at about $115,000. Finally, GAMMA Investing LLC lifted its stake in Axon Enterprise by 11.8% in the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock valued at $765,000 after buying an additional 154 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have commented on AXON. Wolfe Research began coverage on Axon Enterprise in a research note on Monday, July 7th. They set an “outperform” rating for the company. Raymond James Financial reissued an “outperform” rating and issued a $855.00 price objective (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Piper Sandler began coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 target price on the stock. Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the stock an “overweight” rating in a report on Friday, July 11th. Finally, UBS Group reissued a “neutral” rating and issued a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $841.64.

Axon Enterprise Stock Down 0.5%

Shares of NASDAQ:AXON opened at $708.84 on Monday. Axon Enterprise, Inc has a 52-week low of $388.37 and a 52-week high of $885.91. The stock has a market cap of $55.64 billion, a P/E ratio of 175.02, a PEG ratio of 27.53 and a beta of 1.40. The business has a fifty day moving average of $758.60 and a two-hundred day moving average of $703.76. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. During the same quarter in the previous year, the firm earned $1.20 EPS. The company’s quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO Brittany Bagley sold 870 shares of the company’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $773.25, for a total value of $672,727.50. Following the transaction, the chief financial officer directly owned 113,022 shares in the company, valued at approximately $87,394,261.50. This represents a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Monday, August 11th. The stock was sold at an average price of $831.29, for a total value of $8,312,900.00. Following the sale, the chief executive officer directly owned 3,053,982 shares of the company’s stock, valued at approximately $2,538,744,696.78. This trade represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 44,932 shares of company stock worth $34,408,816 over the last ninety days. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.